NSEGeneral Updates6 Aug 2026 · 6 Aug 2026, 06:03 pm
General Updates
Medplus Health Services Limited · MEDPLUS
✦ AI Summary▼ NegativeRegulatory
MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited due to potential revenue loss of Rs 0.24, Rs 0.17, and Rs 0.23 lakhs.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDPLUS_06082026180126_Intimation.pdf
View document text
MedPlus Health Services Limited
August 06, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received three suspension orders for a Drug License of a store situated at below mentioned states:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of the Date of receipt Details of the Impact on
Authority action(s) taken, initiated or of direction or violation(s)/ financial
order(s) passed order, including contravention(s) operation or
any interim or committed or other activities of
interim orders, alleged to be the listed entity,
or any other committed quantifiable in
communication monetary terms
from the to the extent
authority possible
Suspension of Drug License Potential Revenue
Assistant Director, Drugs for one day of store situated Loss of Rs 0.24
Control Administration, at Ashram Road Vijayapura, lacs.
Vijayapura Circle, Karnataka.
Under Rule 65 of
Vijayapura, Karnataka. Suspension of Drug License Order received Potential Revenue
Drugs and Cosmetics
for one day of store situated on 05.08.2026 Loss of Rs 0.17
Act, 1940 and Drugs
at Sindagi, Karnataka. lacs.
and Cosmetics Rules,
Assistand Director, Suspension of Drug License Potential Revenue
1945
Drugs Control for one day of store situated Loss of Rs 0.23
Administration, Raichur at Hanuman Talkies Road, lacs.
Circle, Raichur, Karnataka.
Karnataka.
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
(M. No. F12400)
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com